Molecular Pathways: Dietary Regulation of Stemness and Tumor Initiation by the PPAR-δ Pathway

被引:38
作者
Beyaz, Semir [1 ,2 ,3 ,4 ]
Yilmaz, Omer H. [1 ,2 ,5 ,6 ]
机构
[1] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA
[2] MIT, Dept Biol, Cambridge, MA USA
[3] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA
[4] Harvard Med Sch, Harvard Stem Cell Inst, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA USA
[5] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[6] Harvard Med Sch, Boston, MA USA
关键词
ACTIVATED-RECEPTOR-DELTA; ACID-BINDING PROTEIN; PROLIFERATOR; BETA/DELTA; AGONIST; METABOLISM; POLYMORPHISMS; ADIPOSE; CANCER; CELLS;
D O I
10.1158/1078-0432.CCR-16-0775
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Peroxisome proliferator-activated receptor delta (PPAR-delta) is a nuclear receptor transcription factor that regulates gene expression during development and disease states, such as cancer. However, the precise role of PPAR-delta during tumorigenesis is not well understood. Recent data suggest that PPAR-delta may have context-specific oncogenic and tumor-suppressive roles depending on the tissue, cell-type, or diet-induced physiology in question. For example, in the intestine, pro-obesity diets, such as a high-fat diet (HFD), are associated with increased colorectal cancer incidence. Interestingly, many of the effects of an HFD in the stem and progenitor cell compartment are driven by a robust PPAR-delta program and contribute to the early steps of intestinal tumorigenesis. Importantly, the PPAR-delta pathway or its downstream mediators may serve as therapeutic intervention points or biomarkers in colon cancer that arise in patients who are obese. Although potent PPAR-delta agonists and antagonists exist, their clinical utility may be enhanced by uncovering how PPAR-delta mediates tumorigenesis in diverse tissues and cell types as well as in response to diet. (C) 2016 AACR.
引用
收藏
页码:5636 / 5641
页数:6
相关论文
共 60 条
[1]   Genomewide Analyses Define Different Modes of Transcriptional Regulation by Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) [J].
Adhikary, Till ;
Kaddatz, Kerstin ;
Finkernagel, Florian ;
Schoenbauer, Anne ;
Meissner, Wolfgang ;
Scharfe, Maren ;
Jarek, Michael ;
Bloecker, Helmut ;
Mueller-Bruesselbach, Sabine ;
Mueller, Rolf .
PLOS ONE, 2011, 6 (01)
[2]   Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes -: The STOP-NIDDM trial [J].
Andrulionyte, Laura ;
Peltola, Paula ;
Chiasson, Jean-Louis ;
Laakso, Markku .
DIABETES, 2006, 55 (07) :2148-2152
[3]   Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer [J].
Barak, Y ;
Liao, D ;
He, WM ;
Ong, ES ;
Nelson, MC ;
Olefsky, JM ;
Boland, R ;
Evans, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (01) :303-308
[4]   The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1 [J].
Barroso, Emma ;
Eyre, Elena ;
Palomer, Xavier ;
Vazquez-Carrera, Manuel .
BIOCHEMICAL PHARMACOLOGY, 2011, 81 (04) :534-543
[5]   Alterations of peroxisome proliferator-activated receptor δ activity affect fatty acid-controlled adipose differentiation [J].
Bastie, C ;
Luquet, S ;
Holst, D ;
Jehl-Pietri, C ;
Grimaldi, PA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (49) :38768-38773
[6]   MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin [J].
Bays, Harold E. ;
Schwartz, Sherwyn ;
Littlejohn, Thomas, III ;
Kerzner, Boris ;
Krauss, Ronald M. ;
Karpf, David B. ;
Choi, Yun-Jung ;
Wang, Xueyan ;
Naim, Sue ;
Roberts, Brian K. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (09) :2889-2897
[7]   High-fat diet enhances stemness and tumorigenicity of intestinal progenitors [J].
Beyaz, Semir ;
Mana, Miyeko D. ;
Roper, Jatin ;
Kedrin, Dmitriy ;
Saadatpour, Assieh ;
Hong, Sue Jean ;
Bauer-Rowe, Khristian E. ;
Xifaras, Michael E. ;
Akkad, Adam ;
Arias, Erika ;
Pinello, Luca ;
Katz, Yarden ;
Shinagare, Shweta ;
Abu-Remaileh, Monther ;
Mihaylova, Maria M. ;
Lamming, Dudley W. ;
Dogum, Rizkullah ;
Guo, Guoji ;
Bell, George W. ;
Selig, Martin ;
Nielsen, G. Petur ;
Gupta, Nitin ;
Ferrone, Cristina R. ;
Deshpande, Vikram ;
Yuan, Guo-Cheng ;
Orkin, Stuart H. ;
Sabatini, David M. ;
Yilmaz, Oemer H. .
NATURE, 2016, 531 (7592) :53-+
[8]   Ligand activation of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) inhibits chemically induced skin tumorigenesis [J].
Bility, Moses T. ;
Devlin-Durante, Meghann K. ;
Blazanin, Nicholas ;
Glick, Adam B. ;
Ward, Jerrold M. ;
Kang, Boo Hyon ;
Kennett, Mary J. ;
Gonzalez, Frank J. ;
Peters, Jeffrey M. .
CARCINOGENESIS, 2008, 29 (12) :2406-2414
[9]   Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia [J].
Choi, Yun-Jung ;
Roberts, Brian K. ;
Wang, Xueyan ;
Geaney, J. Casey ;
Naim, Sue ;
Wojnoonski, Kathleen ;
Karpf, David B. ;
Krauss, Ronald M. .
ATHEROSCLEROSIS, 2012, 220 (02) :470-476
[10]   PPARβ/δ Activation Induces Enteroendocrine L Cell GLP-1 Production [J].
Daoudi, Mehdi ;
Hennuyer, Nathalie ;
Borland, Michael G. ;
Touche, Veronique ;
Duhem, Christian ;
Gross, Barbara ;
Caiazzo, Robert ;
Kerr-Conte, Julie ;
Pattou, Francois ;
Peters, Jeffrey M. ;
Staels, Bart ;
Lestavel, Sophie .
GASTROENTEROLOGY, 2011, 140 (05) :1564-1574